News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shenzhen Kangtai's Hepatitis B Vaccine Implicated In Six Deaths


12/27/2013 8:43:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

December 26, 2013 -- In China, eight young children have died after developing adverse reactions to a hepatitis B vaccine. Six of the newborns were given vaccines produced by Shenzhen Kangtai Biological Products, China’s largest provider of hepatitis B vaccines with a 60% market share. China regulators have stopped all use of Kangtai’s vaccine, pending an investigation. Two other children have died following administration of a vaccine made by Beijing Tiantan Biological Products. So far, authorities have not restricted use of Tiantan’s products. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES